Connection

Julio Lorenzi to Spike Glycoprotein, Coronavirus

This is a "connection" page, showing publications Julio Lorenzi has written about Spike Glycoprotein, Coronavirus.
  1. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature. 2021 07; 595(7866):278-282.
    View in: PubMed
    Score: 0.026
  2. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife. 2020 10 28; 9.
    View in: PubMed
    Score: 0.025
  3. Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice. Nature. 2021 05; 593(7859):424-428.
    View in: PubMed
    Score: 0.006
  4. Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients. J Infect Dis. 2021 02 13; 223(3):389-398.
    View in: PubMed
    Score: 0.006
  5. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021 03; 591(7851):639-644.
    View in: PubMed
    Score: 0.006
  6. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med. 2020 11 02; 217(11).
    View in: PubMed
    Score: 0.006
  7. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020 08; 584(7821):437-442.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.